JNK Protein Triggers Nerve Cells to Withdraw Their Synapses when Stressed
Blocking activation of the JNK protein in synapses stops synapses from retracting. Temporal colour coding shows that when the JNK protein is inhibited in synapses using a light beam, a structural protein called “actin” freezes in time. Changing the cells cytoskeleton is part of an array of molecular events that JNK triggers to destabilize synapses.
Synapses are tiny cell protrusions where electrochemical impulses pass between nerves. Prolonged stress in the brain causes synapse withdrawal and maladaptive changes to circuits that are linked to the development of major depressive disorder.
Postdoctoral Researcher Patrik Hollós and colleagues used a light-activated optogenetic tool to switch off the activity of a protein called JNK specifically in synapses.
– Using a light beam to inhibit the JNK protein prevented synapses from shrinking in response to stress. Specifically the internalisation of a receptor called “AMPAR”, an early event in synapse disassembly, was blocked, explains Hollós.
JNK Is a Stress Sensor in Synapses and May Elicit the Effects of Ketamine
Researchers also found that the novel, fast-acting anti-depressant ketamine inhibited the JNK protein while preventing synapse retraction.
– These results show that the JNK protein is a stress sensor in synapses. When activated, it triggers the disassembly of synapse machinery followed by rapid synapse regression. Conversely, inhibiting the JNK protein makes synapses able to withstand chronic endocrine stress. This may be relevant for conditions where hormonal stress leads to synapse elimination but also to control synapse number under normal homeostatic conditions, says team leader Eleanor Coffey.
These findings help us to understand how stress dismantles synapses, and provides clues for novel targeted therapies.
The study was published as a research highlight in the open access journal of the Society for Neuroscience, eNeuro.
Research was conducted at Turku Bioscience Centre a joint research facility of the University of Turku and Åbo Akademi University.
For more information contact Research Director Eleanor Coffey, Turku Bioscience, eleanor.coffey@bioscience.fi
Recent Posts
- The Academy of Finland granted Johanna Ivaska €2,400,000 in funding for an Academy Professor position The Academy of Finland granted our Group Leader, Professor Johanna Ivaska €2,400,000 in funding for Read moreOctober 30, 2025
- Guillaume Jacquemet and Cecilia Sahlgren receive funding for the Research Council of Finland Centre of Excellence in Immune-Endothelial Interactions (IMMENs) Associate Professor Guillaume Jacquemet, our Group Leader, and Professor Cecilia Sahlgren, our affiliated Group Leader, Read moreOctober 30, 2025
- Registration to AI2Med imaging event is now open! Registration for AI2Med Turku 2025 is open! The event is organized by the Turku PET Read moreOctober 21, 2025
- Jonna Alanko receives the Young Investigator Award from the Scandinavian Society for Immunology Jonna Alanko has received the Young Investigator Award of the Scandinavian Society for Immunology. The Read moreOctober 17, 2025
- Professor Riitta Lahesmaa awarded Johnny Ludvigsson Prize for Outstanding Nordic Researcher Professor Riitta Lahesmaa was awarded Johnny Ludvigsson Prize for Outstanding Nordic Researcher. The prize is Read moreOctober 16, 2025
- PFAS levels in mothers’ blood associated with children’s brain structure and function Researchers from the University of Turku and Turku University Hospital, Finland, and Örebro University, Sweden, Read moreOctober 13, 2025